Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.
CONCLUSION: Our case highlights the profound effect of alemtuzumab on the immune system and its possible risk for autoimmune complications.
PMID: 30307371 [PubMed - as supplied by publisher]
Source: Nuklearmedizin - Category: Radiology Authors: Graf J, Ringelstein M, Lepka K, Schaller J, Quack H, Hartung HP, Aktas O, Albrecht P Tags: Mult Scler Source Type: research